US Stock MarketDetailed Quotes
MCRB Seres Therapeutics
- 0.754
- -0.060-7.36%
Trading Nov 21 11:15 ET
128.74MMarket Cap-3590P/E (TTM)
0.880High0.750Low2.53MVolume0.830Open0.814Pre Close2.08MTurnover2.03%Turnover RatioLossP/E (Static)170.74MShares2.05052wk High5.39P/B94.15MFloat Cap0.54052wk Low--Dividend TTM124.86MShs Float52.000Historical High--Div YieldTTM15.87%Amplitude0.540Historical Low0.823Avg Price1Lot Size
Seres Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -60.67%66.82M | -68.96%71.23M | 4.36%111.18M | -29.43%127.97M | -29.43%127.97M | -27.08%169.91M | 17.22%229.52M | -57.04%106.54M | -37.62%181.34M | -37.62%181.34M |
| -Cash and cash equivalents | -60.67%66.82M | -68.96%71.23M | 17.23%111.18M | -21.51%127.97M | -21.51%127.97M | -17.28%169.91M | 80.98%229.52M | -38.09%94.84M | -9.43%163.03M | -9.43%163.03M |
| -Short-term investments | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -87.66%11.7M | -83.46%18.31M | -83.46%18.31M |
| Receivables | ---- | 146.08%18.6M | --7.42M | --8.67M | --8.67M | --16.86M | --7.56M | ---- | --0 | --0 |
| -Related party accounts receivable | ---- | 146.08%18.6M | --7.42M | --8.67M | --8.67M | --16.86M | --7.56M | ---- | --0 | --0 |
| Inventory | ---- | 892.45%53M | --41.97M | --29.65M | --29.65M | --18.53M | --5.34M | ---- | --0 | --0 |
| Other current assets | -32.92%6.1M | -27.03%6.44M | -51.70%4.61M | -32.03%9.12M | -32.03%9.12M | -37.28%9.1M | -36.02%8.82M | -37.46%9.54M | 3.88%13.42M | 3.88%13.42M |
| Total current assets | -65.98%72.93M | -40.59%149.27M | 42.30%165.18M | -9.94%175.41M | -9.94%175.41M | -13.38%214.39M | 19.88%251.24M | -55.90%116.08M | -35.85%194.76M | -35.85%194.76M |
| Non current assets | ||||||||||
| Net PPE | -27.49%95.48M | 19.09%159.95M | -6.33%124.78M | -1.28%132.25M | -1.28%132.25M | 204.58%131.67M | 201.68%134.31M | 194.01%133.22M | 270.63%133.97M | 270.63%133.97M |
| -Gross PPE | -18.57%147.65M | 17.28%213.77M | -1.38%177.18M | 2.45%183.39M | 2.45%183.39M | 104.88%181.32M | 107.03%182.28M | 106.15%179.66M | 134.26%179.01M | 134.26%179.01M |
| -Accumulated depreciation | -5.08%-52.17M | -12.19%-53.82M | -12.83%-52.4M | -13.54%-51.14M | -13.54%-51.14M | -9.68%-49.65M | -10.21%-47.97M | -11.00%-46.44M | -11.85%-45.04M | -11.85%-45.04M |
| Related parties assets | ---- | 146.08%18.6M | --7.42M | --8.67M | --8.67M | --16.86M | --7.56M | ---- | --0 | --0 |
| Other non current assets | -52.21%10.34M | -39.96%12.51M | 145.52%51.3M | 154.05%50.94M | 154.05%50.94M | 2.41%21.63M | 9.14%20.84M | 84.45%20.89M | 37.43%20.05M | 37.43%20.05M |
| Total non current assets | -30.98%105.81M | 11.16%172.47M | 14.25%176.08M | 18.94%183.19M | 18.94%183.19M | 138.22%153.31M | 143.88%155.15M | 172.10%154.11M | 200.64%154.02M | 200.64%154.02M |
| Total assets | -51.39%178.74M | -20.83%321.73M | 26.30%341.26M | 2.81%358.6M | 2.81%358.6M | 17.90%367.7M | 48.75%406.39M | -15.54%270.19M | -1.71%348.78M | -1.71%348.78M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -81.03%8.25M | 8.10%47.88M | 236.91%41.43M | -39.30%31.69M | -39.30%31.69M | 316.32%43.5M | 216.57%44.29M | 81.08%12.3M | 280.12%52.21M | 280.12%52.21M |
| -accounts payable | -7.86%8.25M | -62.78%4.81M | -57.56%5.22M | -79.12%3.64M | -79.12%3.64M | -14.27%8.96M | -7.65%12.92M | 81.08%12.3M | 26.97%17.44M | 26.97%17.44M |
| -Due to related parties current | ---- | 37.30%43.08M | --36.21M | -19.32%28.05M | -19.32%28.05M | --34.54M | --31.37M | ---- | --34.77M | --34.77M |
| Current accrued expenses | 135.14%46.12M | 76.61%43.28M | 5.88%40.11M | 109.64%52.56M | 109.64%52.56M | -21.72%19.62M | 2.85%24.51M | 105.09%37.88M | 4.48%25.07M | 4.48%25.07M |
| Current debt and capital lease obligation | 32.90%8.35M | 68.10%9.2M | 84.64%8.83M | 64.58%6.68M | 64.58%6.68M | -14.36%6.28M | -22.50%5.47M | -30.15%4.78M | -38.62%4.06M | -38.62%4.06M |
| -Current debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --456K | --456K |
| -Current capital lease obligation | 32.90%8.35M | 68.10%9.2M | 84.64%8.83M | 85.42%6.68M | 85.42%6.68M | -14.36%6.28M | -22.50%5.47M | -30.15%4.78M | -45.52%3.6M | -45.52%3.6M |
| Current deferred liabilities | ---- | 118.36%7.92M | 241.29%8.11M | 81.50%7.73M | 81.50%7.73M | 101.91%9.83M | -67.31%3.63M | -88.38%2.38M | -74.68%4.26M | -74.68%4.26M |
| Other current liabilities | --2.11M | ---- | ---- | ---- | ---- | ---- | ---- | -78.25%6.48M | ---- | ---- |
| Current liabilities | -18.17%64.83M | 39.00%108.28M | 54.31%98.48M | 15.26%98.66M | 15.26%98.66M | -3.17%79.23M | -12.51%77.9M | -22.51%63.82M | 4.06%85.6M | 4.06%85.6M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -58.61%85.27M | -1.94%203.43M | 30.03%205.35M | 30.74%207.26M | 30.74%207.26M | 199.82%206M | 195.73%207.45M | 123.11%157.93M | 272.13%158.53M | 272.13%158.53M |
| -Long term debt | ---- | 1.74%102.49M | 99.10%102.01M | 100.72%101.54M | 100.72%101.54M | 98.86%101.14M | 98.97%100.74M | 1.58%51.23M | 105.30%50.59M | 105.30%50.59M |
| -Long term capital lease obligation | -18.69%85.27M | -5.41%100.94M | -3.14%103.34M | -2.06%105.72M | -2.06%105.72M | 487.47%104.86M | 446.76%106.71M | 424.39%106.69M | 501.08%107.94M | 501.08%107.94M |
| Non current deferred liabilities | ---- | 0.46%95.36M | 0.56%95.36M | 3.17%95.36M | 3.17%95.36M | 2.44%95.06M | 5.46%94.93M | 15.82%94.84M | 6.24%92.43M | 6.24%92.43M |
| Non current accrued expenses | --2.94M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Derivative product liabilities | --0 | --0 | --130K | --546K | --546K | --956K | --1.97M | ---- | --0 | --0 |
| Other non current liabilities | 12.92%1.78M | 12.86%1.73M | 12.92%1.68M | 12.90%1.63M | 12.90%1.63M | 64.31%1.58M | 62.46%1.53M | -61.98%1.49M | -87.46%1.44M | -87.46%1.44M |
| Total non current liabilities | -70.36%89.99M | -1.75%300.52M | 18.99%302.52M | 20.76%304.8M | 20.76%304.8M | 86.87%303.6M | 89.87%305.88M | 62.38%254.25M | 78.89%252.41M | 78.89%252.41M |
| Total liabilities | -59.56%154.82M | 6.52%408.81M | 26.07%401M | 19.37%403.46M | 19.37%403.46M | 56.71%382.82M | 53.42%383.77M | 33.12%318.07M | 51.33%338M | 51.33%338M |
| Shareholders'equity | ||||||||||
| Share capital | 31.78%170K | 18.75%152K | 18.90%151K | 8.00%135K | 8.00%135K | 4.03%129K | 39.13%128K | 38.04%127K | 35.87%125K | 35.87%125K |
| -common stock | 31.78%170K | 18.75%152K | 18.90%151K | 8.00%135K | 8.00%135K | 4.03%129K | 39.13%128K | 38.04%127K | 35.87%125K | 35.87%125K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -2.72%-962.46M | -18.23%-1.05B | -8.84%-1.02B | -13.15%-978.24M | -13.15%-978.24M | -17.75%-936.99M | -20.85%-889.13M | -39.45%-935.69M | -40.72%-864.51M | -40.72%-864.51M |
| Paid-in capital | 7.00%986.21M | 5.75%964.01M | 7.98%958.48M | 6.63%933.24M | 6.63%933.24M | 6.77%921.74M | 20.12%911.62M | 18.03%887.69M | 17.34%875.18M | 17.34%875.18M |
| Gains losses not affecting retained earnings | --0 | --0 | --0 | --0 | --0 | --0 | 99.61%-1K | 100.93%2K | 80.00%-12K | 80.00%-12K |
| Total stockholders'equity | 258.16%23.92M | -485.04%-87.07M | -24.79%-59.74M | -515.99%-44.86M | -515.99%-44.86M | -122.38%-15.12M | -1.93%22.61M | -159.13%-47.87M | -91.80%10.78M | -91.80%10.78M |
| Total equity | 258.16%23.92M | -485.04%-87.07M | -24.79%-59.74M | -515.99%-44.86M | -515.99%-44.86M | -122.38%-15.12M | -1.93%22.61M | -159.13%-47.87M | -91.80%10.78M | -91.80%10.78M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
